Literature DB >> 26297384

Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Raehannah J Jamshidi1, Blaine A Jacobs1, Laura C Sullivan1, Teresa A Chavera1, Rachel M Saylor1, Thomas E Prisinzano1, William P Clarke1, Kelly A Berg2.   

Abstract

Activation of kappa opioid receptors (KORs) expressed by peripheral sensory neurons that respond to noxious stimuli (nociceptors) can reduce neurotransmission of pain stimuli from the periphery to the central nervous system. We have previously shown that the antinociception dose-response curve for peripherally restricted doses of the KOR agonist (-)-(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U50488) has an inverted U shape. Here, we found that the downward phase of the U50488 dose-response curve was blocked by an inhibitor of extracellular signal-regulated kinase (ERK) activation U0126. Local administration of the selective KOR agonist salvinorin A (Sal-A), also resulted in an inverted U-shaped curve; however, the downward phase was insensitive to U0126. By contrast, inhibition of c-Jun N-terminal kinase (JNK) partially blocked the downward phase of the dose-response curve to Sal-A, suggesting a role for JNK. In cultures of peripheral sensory neurons, U50488 and Sal-A inhibited adenylyl cyclase activity with similar efficacies; however, their ability to activate ERK and JNK differed. Whereas U50488 activated ERK but not JNK, Sal-A activated JNK but not ERK. Moreover, although both U50488 and Sal-A produced homologous desensitization, desensitization to U50488 was blocked by inhibition of ERK activation, whereas desensitization to Sal-A was blocked by inhibition of JNK. Substitution of an ethoxymethyl ether for the C2 position acetyl group of Sal-A reduced stimulation of JNK, prevented desensitization by ethoxymethyl ether for the C2 position acetyl group of Sal-A, and resulted in a monotonic antinociception dose-response curve. Collectively, these data demonstrate the functional selectivity of KOR ligands for signaling in peripheral sensory neurons, which results in differential effects on behavioral responses in vivo.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26297384      PMCID: PMC4613959          DOI: 10.1124/jpet.115.225896

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  57 in total

Review 1.  Opioids and sensory nerves.

Authors:  Christoph Stein; Christian Zöllner
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Regulation of opioid receptors in rat sensory neurons in culture.

Authors:  J J Chen; J Dymshitz; M R Vasko
Journal:  Mol Pharmacol       Date:  1997-04       Impact factor: 4.436

Review 3.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

Review 4.  Delta and kappa opioid receptors as suitable drug targets for pain.

Authors:  Todd W Vanderah
Journal:  Clin J Pain       Date:  2010-01       Impact factor: 3.442

Review 5.  Kinase cascades and ligand-directed signaling at the kappa opioid receptor.

Authors:  Michael R Bruchas; Charles Chavkin
Journal:  Psychopharmacology (Berl)       Date:  2010-04-17       Impact factor: 4.530

6.  Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability.

Authors:  Hui Zheng; Yan Zeng; Ji Chu; Angel YuetFang Kam; Horace H Loh; Ping-Yee Law
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

7.  Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.

Authors:  Ilona Obara; Jan Rodriguez Parkitna; Michal Korostynski; Wioletta Makuch; Dorota Kaminska; Barbara Przewlocka; Ryszard Przewlocki
Journal:  Pain       Date:  2009-01-14       Impact factor: 6.961

8.  mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD.

Authors:  Hui Zheng; Yan Zeng; Xiaoxiao Zhang; Ji Chu; Horace H Loh; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2009-10-23       Impact factor: 4.436

Review 9.  MAP kinase and pain.

Authors:  Ru-Rong Ji; Robert W Gereau; Marzia Malcangio; Gary R Strichartz
Journal:  Brain Res Rev       Date:  2008-12-25

10.  Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.

Authors:  C P Bailey; S Oldfield; J Llorente; C J Caunt; A G Teschemacher; L Roberts; C A McArdle; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

View more
  15 in total

1.  Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.

Authors:  Blaine A Jacobs; Miryam M Pando; Elaine M Jennings; Raehannah J Jamshidi; Joshua C Zamora; Teresa S Chavera; William P Clarke; Kelly A Berg
Journal:  Neuropharmacology       Date:  2019-02-15       Impact factor: 5.250

2.  Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by Gs and Gi/o Proteins.

Authors:  Susanne Neumann; Sarah S Malik; Bernice Marcus-Samuels; Elena Eliseeva; Daesong Jang; Joanna Klubo-Gwiezdzinska; Christine C Krieger; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2019-11-08       Impact factor: 4.436

3.  Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.

Authors:  Raehannah J Jamshidi; Laura C Sullivan; Blaine A Jacobs; Teresa A Chavera; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-07       Impact factor: 4.030

4.  The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.

Authors:  Amy W M Ewald; Peter J Bosch; Aimee Culverhouse; Rachel Saylor Crowley; Benjamin Neuenswander; Thomas E Prisinzano; Bronwyn M Kivell
Journal:  Psychopharmacology (Berl)       Date:  2017-05-23       Impact factor: 4.530

5.  Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Authors:  Blaine A Jacobs; Miryam M Pando; Elaine Jennings; Teresa A Chavera; William P Clarke; Kelly A Berg
Journal:  Mol Pharmacol       Date:  2018-02-07       Impact factor: 4.436

6.  Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Authors:  Laura C Sullivan; Teresa A Chavera; Xiaoli Gao; Miryam M Pando; Kelly A Berg
Journal:  J Pharmacol Exp Ther       Date:  2017-05-02       Impact factor: 4.030

Review 7.  Designing Safer Analgesics via μ-Opioid Receptor Pathways.

Authors:  H C Stephen Chan; Dillon McCarthy; Jianing Li; Krzysztof Palczewski; Shuguang Yuan
Journal:  Trends Pharmacol Sci       Date:  2017-09-19       Impact factor: 14.819

8.  Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Authors:  Laura C Sullivan; Teresa S Chavera; Raehannah J Jamshidi; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-22       Impact factor: 4.030

Review 9.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

10.  Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.

Authors:  Yi-Ting Chiu; Chongguang Chen; Daohai Yu; Stefan Schulz; Lee-Yuan Liu-Chen
Journal:  Mol Pharmacol       Date:  2017-09-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.